FILE PHOTO: Syringes filled with a dose of the Pfizer-BioNTech coronavirus disease vaccine are prepared at the CHIREC Delta Hospital in Brussels, Belgium January 21, 2021. REUTERS/Yves Herman/File Photo
BioNTech declined to comment while Pfizer did not respond to requests for comment. Spokespeople for the WHO and the GAVI vaccine alliance, which co-leads the COVAX scheme, also declined to comment. Ukraine said earlier on Thursday that its first delievery of COVID-19 vaccine under the COVAX scheme could arrive in the first half on February - with 210,000 doses of either the Moderna, Pfizer or AstraZeneca vaccines.
COVAX has so far secured future vaccine suplies from AstraZeneca, working with Oxford University; the Serum Institute of India as well as with Sanofi and its partner GSK. It also has a memorandum of understanding over deliveries from Johnson & Johnson. The Pfizer and BioNTech COVID-19 vaccine is the only shot so far to have WHO emergency use listing approval.
Because there was a dead person. Now sharing the scheme source. Business that was lost in the rush. Because it's not instant noodles that make instant vaccines.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.